ROANOKE TIMES 

                         Roanoke Times
                 Copyright (c) 1995, Landmark Communications, Inc.

DATE: THURSDAY, June 2, 1994                   TAG: 9406020067
SECTION: NATIONAL/INTERNATIONAL                    PAGE: A-7   EDITION: METRO 
SOURCE: 
DATELINE: WASHINGTON                                LENGTH: Short

FDA APPROVES NEW MEDICATION FOR TB

The Food and Drug Administration approved a new three-in-one tuberculosis pill Wednesday in an effort to fight the increasingly drug-resistant disease.

Rifater, developed by Marion Merrell Dow Inc., combines the world's top TB drugs - rifampin, isoniazid and pyrazinamide - making it easier for patients to take their medicine as prescribed.

"That sounds sort of simple but it's really very important because ...TB becomes drug resistant when patients don't take their medicine properly," said American Lung Association President Dr. Joseph Bates.

- Associated Press 


 by CNB